Familial neuroblastoma: Report of a kindred with later age at diagnosis

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 5, 1998, Pages 489-493

  Lemire, Edmond G ^a   Chodirker, Bernard N ^a   Williams, Gaynor J ^a   Seargeant, Lorne E ^a   Israels, Sara J ^a   Phillips, Susan M ^a   De Nanassy, Joseph A ^a   Maris, John M ^b   Yanofsky, Rochelle A ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Familial; Neuroblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHILD; FAMILIAL CANCER; FEMALE; HUMAN; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; RELATIVE; SIBLING;

AGE OF ONSET; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, MYC; GENETIC MARKERS; HUMANS; MALE; NEUROBLASTOMA; PEDIGREE;

EID: 0032455057     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199809000-00017     Document Type: Article

References (28)

1. Brodeur GM. Clinical and biological aspects of neuroblastoma. In: CR Scriver, AL Beaudet, WS Sly, et al., eds. The metabolic and molecular bases of inherited disease, 7th ed. New York, NY: McGraw-Hill, 1995:697-716.
2. Chatten J, Voorhess ML. Familial neuroblastoma: report of a kindred with multiple disorders, including neuroblastomas in four siblings. N Engl J Med 1967;277:1230-6.
3. Hardy PC, Nesbit ME. Familial neuroblastoma: report of a kindred with a high incidence of infantile tumors. J Pediatr 1972;80:74-7.
4. Pegelow CH, Ebbin AJ, Powars D, et al. Familial neuroblastoma. J Pediatr 1975;87:763-5.
5. Arenson EB Jr, Hutter JJ Jr, Restuccia RD, et al. Neuroblastoma in father and son. JAMA 1976;235:727-9.
6. Hecht F, Kaiser Hecht B, Northup JC, et al. Genetics of familial neuroblastoma: long-range studies. Cancer Genet Cytogenet 1982;7: 227-30.
7. Kushner BH, Gilber F, Helson L. Familial neuroblastoma: case reports, literature review, and etiologic considerations. Cancer 1986;57:1887-93.
8. Clausen N, Andersson P, Tommerup N. Familial occurrence of neuroblastoma, Von Recklinghausen's neurofibromatosis, Hirschsprung's agangliosis and jaw-winking syndrome. Acta Paediatr Scand 1989;78:736-41.
9. Maris JM, Chatten J, Meadows AT, et al. Familial neuroblastoma: a three-generation pedigree and a further association with Hirschsprung disease. Med Pediatr Oncol 1997;28:1-5.
10. Brodeur GM and Nakagawara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 1992; 14(2):111-16.
11. Biegel JA, White PS, Marshall HN, et al. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 1993;52:176-82.
12. Knudson AG Jr, Strong LC. Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 1972;24:514-32.
13. Maris JM, Kyemba SM, Rebbeck TR, et al. Molecular genetic analysis of familial neuroblastoma. Eur J Cancer 1997;33:1923-8.
14. Mans JM, Kyemba SM, Rebbeck TR, et al. Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 1996;56:3421-5.
15. Shimada H, Chatten J, Newton WA Jr. et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma. An age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-13.
16. Mitelman F, ed. ISCN (1995): an international system for human cytogenetic nomenclature. Basel: S. Karger, 1995.
17. Crabbe DC, Peters J, Seeger RC. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diagn Mol Pathol 1992;1:229-34.
18. Seeger RC, Wada R, Brodeur GM, et al. Expression of MYCN by neuroblastomas with one or multiple copies of the oncogene. Prog Clin Biol Res 1988;271:41-9.
19. Slamon DJ, Boone TC, Seeger RC, et al. Identification and characterization of the protein encoded by the human MYCN oncogene. Science 1986;232:768-72. .
20. Maris JM, White PS, Beltinger CP, et al. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 1995;55:4664-9.
21. Maris JM, Wiersma SR, Mahgoub N, et al. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Cancer 1997;79:1438-46.
22. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the International Criteria for Neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
23. Gerson JM, Chatten J and Eisman S. Familial neuroblastoma - a follow up. N Engl J Med 1974;290:1487-8.
24. Murphy SB, Cohn SL, Craft AW, et al. Do children benefit from mass screening for neuroblastoma? Consensus statement from the American Cancer Society workshop on neuroblastoma screening. Lancet 1991;337:344-5.
25. Woods WG, Tuchman M, Robison LL, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996;348:1682-7.
26. Woods WG, Tuchman M, Bernstein ML, et al. Screening for neuroblastoma in North America: 2-year results from the Quebec project. Am J Pediatr Hematol Oncol 1992;14:312-9.
27. Hayashi Y, Ohi R, Yaoita S, et al. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds. J Pediatr Surg 1995;30:467-70.
28. Suita S, Zaizen Y, Sera Y, et al. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan. J Pediatr Surg 1996;31:555-8.